Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.3610
-0.0040 (-1.10%)
Dec 12, 2025, 10:07 AM EST - Market open
Vaxart Market Cap
Vaxart has a market cap or net worth of $86.48 million as of December 12, 2025. Its market cap has decreased by -37.89% in one year.
Market Cap
86.48M
Enterprise Value
77.60M
1-Year Change
-37.89%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from $60.35M to $86.48M, an increase of 43.30%. That is a compound annual growth rate of 4.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 87.44M | -41.95% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | 625.07M | 3,636.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |